According to the group, it is imperative that the panel consist of a range of truly independent global public health thinkers from diverse fields who are free from influence from the WHO, its director-General or member states.
During and after the 2014-2016 West Africa Ebola crisis, several independent panels were formed to evaluate the global response to that disaster; however, none were chaired by former heads of state and all panels concluded with recommendations of reforms of WHO.
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.4 m people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe.
Roche expands cyclospora testing portfolio to support US public health response
Decoy Therapeutics expands antiviral platform into Ebola and filovirus research
Aptamer Group launches Optimer-based Ebola diagnostic programme
Physiomics secures new contracts worth over GBP200,000
EDX Medical to provide molecular profiling services to Astron Health
Sanofi appoints new global head of Research & Development Pharma
Lakewood-Amedex expands intellectual property portfolio with Australian Bisphosphocin patent
Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
RedHill Biopharma advancing opaganib options for Ebola outbreak
Transgene to present preclinical TG-MVA mpox vaccine data at World Congress on Infectious Diseases